Wikidata

(Q73117996)

English

Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group

scientific article published on 01 October 2000

In more languages

Statements

title
Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11049104
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11049104%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q73117996&oldid=2172855321"